{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_15092", "batch_size": 260, "batch_pos": 7, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment reports stock price movement factually; 'climbed' is not high-potency about the threat's impact.", "method": "llm_batch", "batch_id": "batch_2_15020", "batch_size": 260, "batch_pos": 241, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "Reports financial metrics, which are Neutral.", "method": "llm_batch", "batch_id": "batch_3_15688", "batch_size": 260, "batch_pos": 176, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_17420", "batch_size": 260, "batch_pos": 165, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "Reports stock movement and potential funding but lacks explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_1504", "batch_size": 260, "batch_pos": 162, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser + scale contrast.", "method": "llm_batch", "batch_id": "batch_6_14128", "batch_size": 260, "batch_pos": 132, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation about risk, cases, or capability.", "method": "llm_batch", "batch_id": "batch_7_17788", "batch_size": 260, "batch_pos": 112, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 8, "answer": "no", "rationale": "The segment reports market reaction and potential funding, not a capability or preparedness measure itself.", "method": "llm_batch", "batch_id": "batch_8_1004", "batch_size": 260, "batch_pos": 230, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 9, "answer": "yes", "rationale": "Reports stock price change ('climbed 2.4%') using a standard verb and numerical metric.", "method": "llm_batch", "batch_id": "batch_9_8472", "batch_size": 260, "batch_pos": 127, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
